PlainRecalls
FDA Drug Low Class III Terminated

Morphine Sulfate Extended-Release Tablets, 15 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-540-01

Reported: May 1, 2019 Initiated: April 10, 2019 #D-1243-2019

Product Description

Morphine Sulfate Extended-Release Tablets, 15 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-540-01

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
LUPIN SOMERSET
Units Affected
17,328 bottles
Distribution
Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.
Location
Somerset, NJ

Frequently Asked Questions

What product was recalled?
Morphine Sulfate Extended-Release Tablets, 15 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-540-01. Recalled by LUPIN SOMERSET. Units affected: 17,328 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2019. Severity: Low. Recall number: D-1243-2019.